Research Analysts’ Price Target Changes for November 4th (ADUS, AESI, AGCO, ALAB, ALKS, ALSN, AMD, AME, AMGN, AMWL)

Research Analysts’ price target changes for Wednesday, November 4th:

Addus HomeCare (NASDAQ:ADUS) had its price target boosted by Barclays from $96.00 to $101.00. They currently have an underweight rating on the stock.

Atlas Energy Solutions (NYSE:AESI) had its price target lowered by Royal Bank Of Canada from $16.00 to $13.00. The firm currently has a sector perform rating on the stock.

Atlas Energy Solutions (NYSE:AESI) had its price target reduced by Piper Sandler from $15.00 to $13.00. Piper Sandler currently has a neutral rating on the stock.

AGCO (NYSE:AGCO) had its target price raised by Morgan Stanley from $99.00 to $113.00. The firm currently has an underweight rating on the stock.

Astera Labs (NASDAQ:ALAB) had its target price boosted by Morgan Stanley from $382.00 to $389.00. The firm currently has an overweight rating on the stock.

Astera Labs (NASDAQ:ALAB) had its target price trimmed by Royal Bank Of Canada from $500.00 to $400.00. They currently have an outperform rating on the stock.

Astera Labs (NASDAQ:ALAB) had its target price cut by Susquehanna from $310.00 to $258.00. The firm currently has a neutral rating on the stock.

Alkermes (NASDAQ:ALKS) had its target price boosted by HC Wainwright from $43.00 to $50.00. HC Wainwright currently has a neutral rating on the stock.

Alkermes (NASDAQ:ALKS) had its target price increased by Royal Bank Of Canada from $56.00 to $57.00. They currently have an outperform rating on the stock.

Allison Transmission (NYSE:ALSN) had its target price raised by Morgan Stanley from $132.00 to $139.00. The firm currently has an equal weight rating on the stock.

Advanced Micro Devices (NASDAQ:AMD) had its target price raised by Piper Sandler from $600.00 to $650.00. They currently have an overweight rating on the stock.

Advanced Micro Devices (NASDAQ:AMD) had its price target raised by DA Davidson from $550.00 to $600.00. They currently have a buy rating on the stock.

AMETEK (NYSE:AME) had its price target cut by Mizuho from $285.00 to $275.00. Mizuho currently has an outperform rating on the stock.

Amgen (NASDAQ:AMGN) had its price target increased by Cantor Fitzgerald from $440.00 to $465.00. They currently have a neutral rating on the stock.

Amgen (NASDAQ:AMGN) had its price target raised by Truist Financial from $380.00 to $398.00. The firm currently has a hold rating on the stock.

Amgen (NASDAQ:AMGN) had its price target boosted by Morgan Stanley from $359.00 to $410.00. The firm currently has an equal weight rating on the stock.

Amgen (NASDAQ:AMGN) had its price target increased by The Goldman Sachs Group from $481.00 to $536.00. They currently have a buy rating on the stock.

American Well (NYSE:AMWL) had its target price boosted by Wells Fargo & Company from $16.00 to $18.00. The firm currently has an overweight rating on the stock.

American Well (NYSE:AMWL) had its target price raised by Stifel Nicolaus from $11.00 to $12.00. The firm currently has a hold rating on the stock.

Arista Networks (NYSE:ANET) had its price target increased by Truist Financial from $234.00 to $240.00. The firm currently has a buy rating on the stock.

Arista Networks (NYSE:ANET) had its target price cut by Barclays from $289.00 to $236.00. The firm currently has an overweight rating on the stock.

Arista Networks (NYSE:ANET) had its price target raised by Piper Sandler from $240.00 to $261.00. Piper Sandler currently has an overweight rating on the stock.

Angel Oak Mortgage REIT (NYSE:AOMR) had its target price reduced by B. Riley Financial from $13.00 to $10.00. B. Riley Financial currently has a buy rating on the stock.

Apollo Global Management (NYSE:APO) had its price target trimmed by Royal Bank Of Canada from $146.00 to $138.00. They currently have a sector perform rating on the stock.

Apollo Global Management (NYSE:APO) had its target price lowered by Barclays from $157.00 to $156.00. The firm currently has an overweight rating on the stock.

Apollo Global Management (NYSE:APO) had its price target trimmed by Keefe, Bruyette & Woods from $135.00 to $130.00. They currently have a market perform rating on the stock.

Apollo Global Management (NYSE:APO) had its target price reduced by Morgan Stanley from $150.00 to $149.00. Morgan Stanley currently has an overweight rating on the stock.

Aptiv (NYSE:APTV) had its price target lowered by Morgan Stanley from $55.00 to $45.00. The firm currently has an equal weight rating on the stock.

Aptiv (NYSE:APTV) had its target price cut by The Goldman Sachs Group from $61.00 to $54.00. The firm currently has a buy rating on the stock.

Aptiv (NYSE:APTV) had its target price trimmed by Barclays from $60.00 to $53.00. The firm currently has an overweight rating on the stock.

Aptiv (NYSE:APTV) had its target price cut by Royal Bank Of Canada from $77.00 to $64.00. Royal Bank Of Canada currently has an outperform rating on the stock.

AtriCure (NASDAQ:ATRC) had its target price boosted by Needham & Company LLC from $64.00 to $70.00. Needham & Company LLC currently has a buy rating on the stock.

Axsome Therapeutics (NASDAQ:AXSM) had its price target reduced by Mizuho from $284.00 to $272.00. The firm currently has an outperform rating on the stock.

Ball (NYSE:BALL) had its target price increased by Mizuho from $72.00 to $75.00. The firm currently has an outperform rating on the stock.

Barclays (LON:BARC) had its target price trimmed by Jefferies Financial Group from GBX 600 to GBX 590. The firm currently has a buy rating on the stock.

Boise Cascade (NYSE:BCC) had its target price cut by Truist Financial from $97.00 to $86.00. Truist Financial currently has a buy rating on the stock.

Beam Therapeutics (NASDAQ:BEAM) had its target price raised by Wedbush from $28.00 to $30.00. They currently have an outperform rating on the stock.

Booking (NASDAQ:BKNG) had its target price cut by Wedbush from $247.00 to $210.00. Wedbush currently has an outperform rating on the stock.

Booking (NASDAQ:BKNG) had its target price trimmed by B. Riley Financial from $274.00 to $265.00. The firm currently has a buy rating on the stock.

Booking (NASDAQ:BKNG) had its price target trimmed by Royal Bank Of Canada from $220.00 to $205.00. They currently have an outperform rating on the stock.

Booking (NASDAQ:BKNG) had its target price lowered by Rosenblatt Securities from $245.00 to $210.00. They currently have a buy rating on the stock.

Booking (NASDAQ:BKNG) had its target price trimmed by Bank of America from $232.00 to $219.00. They currently have a buy rating on the stock.

Booking (NASDAQ:BKNG) had its price target cut by Cantor Fitzgerald from $170.00 to $150.00. They currently have a neutral rating on the stock.

Booking (NASDAQ:BKNG) had its target price reduced by Barclays from $210.00 to $170.00. The firm currently has an overweight rating on the stock.

BioNTech (NASDAQ:BNTX) had its target price lowered by Morgan Stanley from $114.00 to $106.00. They currently have an overweight rating on the stock.

BioNTech (NASDAQ:BNTX) had its price target reduced by Wells Fargo & Company from $140.00 to $125.00. The firm currently has an overweight rating on the stock.

Broadridge Financial Solutions (NYSE:BR) had its price target raised by Morgan Stanley from $176.00 to $181.00. They currently have an equal weight rating on the stock.

Cabot (NYSE:CBT) had its target price lowered by Truist Financial from $100.00 to $95.00. Truist Financial currently has a buy rating on the stock.

Chemours (NYSE:CC) had its target price lowered by Truist Financial from $20.00 to $18.00. They currently have a buy rating on the stock.

Coca-Cola Europacific Partners (NASDAQ:CCEP) had its target price increased by Wells Fargo & Company from $115.00 to $120.00. They currently have an overweight rating on the stock.

Celanese (NYSE:CE) had its price target increased by Barclays from $49.00 to $57.00. The firm currently has an equal weight rating on the stock.

Clorox (NYSE:CLX) had its target price boosted by Morgan Stanley from $87.00 to $94.00. Morgan Stanley currently has an equal weight rating on the stock.

Compass Pathways (NASDAQ:CMPS) had its target price reduced by Wells Fargo & Company from $13.00 to $10.00. The firm currently has an equal weight rating on the stock.

Cinemark (NYSE:CNK) had its price target increased by Wedbush from $45.00 to $46.00. They currently have an outperform rating on the stock.

Crescent Energy (NYSE:CRGY) had its price target raised by Truist Financial from $19.00 to $20.00. Truist Financial currently has a buy rating on the stock.

CRH (NYSE:CRH) had its target price reduced by Morgan Stanley from $139.00 to $129.00. They currently have an overweight rating on the stock.

Camping World (NYSE:CWH) had its target price trimmed by KeyCorp from $8.00 to $7.00. They currently have an overweight rating on the stock.

Community Health Systems (NYSE:CYH) had its price target reduced by Barclays from $2.50 to $2.00. The firm currently has an underweight rating on the stock.

DuPont de Nemours (NYSE:DD) had its target price raised by Barclays from $156.00 to $176.00. The firm currently has an overweight rating on the stock.

Datadog (NASDAQ:DDOG) had its price target cut by BTIG Research from $289.00 to $260.00. They currently have a buy rating on the stock.

Denali Therapeutics (NASDAQ:DNLI) had its target price increased by Morgan Stanley from $40.00 to $42.00. They currently have an overweight rating on the stock.

Denali Therapeutics (NASDAQ:DNLI) had its price target raised by Wedbush from $23.00 to $24.00. They currently have an outperform rating on the stock.

Healthpeak Properties (NYSE:DOC) had its target price trimmed by Cantor Fitzgerald from $23.00 to $21.00. The firm currently has a neutral rating on the stock.

DigitalOcean (NYSE:DOCN) had its price target lowered by Barclays from $161.00 to $140.00. Barclays currently has an overweight rating on the stock.

Amdocs (NASDAQ:DOX) had its target price trimmed by Stifel Nicolaus from $71.00 to $46.00. Stifel Nicolaus currently has a buy rating on the stock.

Dynatrace (NYSE:DT) had its price target reduced by Rosenblatt Securities from $70.00 to $65.00. They currently have a buy rating on the stock.

Dynatrace (NYSE:DT) had its price target reduced by Wedbush from $54.00 to $50.00. They currently have a neutral rating on the stock.

Dynatrace (NYSE:DT) had its target price cut by Wells Fargo & Company from $75.00 to $65.00. The firm currently has an overweight rating on the stock.

Dynatrace (NYSE:DT) had its target price reduced by Barclays from $71.00 to $61.00. Barclays currently has an overweight rating on the stock.

Dynatrace (NYSE:DT) had its price target lowered by Royal Bank Of Canada from $73.00 to $68.00. They currently have an outperform rating on the stock.

Duolingo (NASDAQ:DUOL) had its price target boosted by Barclays from $115.00 to $133.00. The firm currently has an equal weight rating on the stock.

Echostar (NASDAQ:ECHO) had its price target cut by Morgan Stanley from $134.00 to $132.00. Morgan Stanley currently has an overweight rating on the stock.

Everest Group (NYSE:EG) had its target price increased by Keefe, Bruyette & Woods from $407.00 to $450.00. They currently have an outperform rating on the stock.

Eastman Chemical (NYSE:EMN) had its price target boosted by Royal Bank Of Canada from $65.00 to $70.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

EPAM Systems (NYSE:EPAM) had its target price boosted by Morgan Stanley from $97.00 to $140.00. Morgan Stanley currently has an equal weight rating on the stock.

Equitable (NYSE:EQH) had its price target increased by Truist Financial from $60.00 to $65.00. Truist Financial currently has a buy rating on the stock.

Eaton (NYSE:ETN) had its price target boosted by Royal Bank Of Canada from $526.00 to $539.00. They currently have an outperform rating on the stock.

Evertec (NYSE:EVTC) had its target price increased by Keefe, Bruyette & Woods from $38.00 to $42.00. They currently have an outperform rating on the stock.

Expeditors International of Washington (NASDAQ:EXPD) had its price target boosted by Truist Financial from $175.00 to $200.00. They currently have a hold rating on the stock.

Expeditors International of Washington (NASDAQ:EXPD) had its price target increased by Barclays from $165.00 to $175.00. They currently have an underweight rating on the stock.

Diamondback Energy (NASDAQ:FANG) had its price target boosted by Truist Financial from $224.00 to $232.00. Truist Financial currently has a buy rating on the stock.

Diamondback Energy (NASDAQ:FANG) had its target price lowered by Wells Fargo & Company from $263.00 to $244.00. They currently have an overweight rating on the stock.

Fortune Brands Innovations (NYSE:FBIN) had its price target trimmed by Royal Bank Of Canada from $49.00 to $48.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Fortune Brands Innovations (NYSE:FBIN) had its price target raised by Wells Fargo & Company from $48.00 to $51.00. The firm currently has an overweight rating on the stock.

Fortune Brands Innovations (NYSE:FBIN) had its target price lowered by Truist Financial from $70.00 to $60.00. Truist Financial currently has a buy rating on the stock.

Fiserv (NASDAQ:FISV) had its target price increased by Royal Bank Of Canada from $65.00 to $70.00. The firm currently has an outperform rating on the stock.

Fiserv (NASDAQ:FISV) had its target price raised by Keefe, Bruyette & Woods from $60.00 to $70.00. They currently have an outperform rating on the stock.

Fiserv (NASDAQ:FISV) had its target price raised by Morgan Stanley from $59.00 to $61.00. Morgan Stanley currently has an equal weight rating on the stock.

Firefly Aerospace (NASDAQ:FLY) had its price target cut by B. Riley Financial from $50.00 to $40.00. B. Riley Financial currently has a buy rating on the stock.

Freshworks (NASDAQ:FRSH) had its target price boosted by Piper Sandler from $12.00 to $15.00. Piper Sandler currently has a neutral rating on the stock.

Freshworks (NASDAQ:FRSH) had its price target boosted by Cantor Fitzgerald from $15.00 to $20.00. They currently have an overweight rating on the stock.

Sensei Biotherapeutics (NASDAQ:FTH) had its price target trimmed by Guggenheim from $70.00 to $69.00. Guggenheim currently has a buy rating on the stock.

Gaming and Leisure Properties (NASDAQ:GLPI) had its target price lowered by Cantor Fitzgerald from $48.00 to $42.00. Cantor Fitzgerald currently has a neutral rating on the stock.

Graphic Packaging (NYSE:GPK) had its target price increased by Royal Bank Of Canada from $9.00 to $12.00. The firm currently has a sector perform rating on the stock.

Hess Midstream Partners (NYSE:HESM) had its target price lowered by Wells Fargo & Company from $40.00 to $34.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Hamilton Insurance Group (NYSE:HG) had its target price increased by Keefe, Bruyette & Woods from $40.00 to $42.00. They currently have an outperform rating on the stock.

Hagerty (NYSE:HGTY) had its target price raised by Wells Fargo & Company from $14.00 to $17.00. The firm currently has an equal weight rating on the stock.

Hagerty (NYSE:HGTY) had its price target increased by Citizens Jmp from $15.00 to $19.00. They currently have a market outperform rating on the stock.

Hagerty (NYSE:HGTY) had its price target boosted by Truist Financial from $13.00 to $16.00. Truist Financial currently has a hold rating on the stock.

Hamilton Lane (NASDAQ:HLNE) had its target price raised by Wells Fargo & Company from $103.00 to $114.00. They currently have an overweight rating on the stock.

Hamilton Lane (NASDAQ:HLNE) had its target price increased by Keefe, Bruyette & Woods from $116.00 to $120.00. They currently have an outperform rating on the stock.

Hiscox (LON:HSX) had its price target boosted by Berenberg Bank from GBX 2,150 to GBX 2,250. The firm currently has a buy rating on the stock.

Huntsman (NYSE:HUN) had its target price increased by Royal Bank Of Canada from $9.00 to $10.00. The firm currently has a sector perform rating on the stock.

Huron Consulting Group (NASDAQ:HURN) had its target price raised by Wedbush from $160.00 to $220.00. The firm currently has an outperform rating on the stock.

IDEAYA Biosciences (NASDAQ:IDYA) had its price target increased by Wedbush from $60.00 to $63.00. They currently have an outperform rating on the stock.

IDEAYA Biosciences (NASDAQ:IDYA) had its target price cut by Guggenheim from $57.00 to $52.00. They currently have a buy rating on the stock.

IDEAYA Biosciences (NASDAQ:IDYA) had its target price lowered by Royal Bank Of Canada from $48.00 to $45.00. They currently have an outperform rating on the stock.

Innovative Industrial Properties (NYSE:IIPR) had its price target increased by Piper Sandler from $44.00 to $46.00. The firm currently has an underweight rating on the stock.

IPG Photonics (NASDAQ:IPGP) had its target price lowered by Needham & Company LLC from $120.00 to $105.00. They currently have a buy rating on the stock.

Gartner (NYSE:IT) had its price target increased by Morgan Stanley from $182.00 to $192.00. They currently have an equal weight rating on the stock.

Gartner (NYSE:IT) had its price target increased by The Goldman Sachs Group from $181.00 to $207.00. The firm currently has a neutral rating on the stock.

Janus Living (NYSE:JAN) had its price target trimmed by Cantor Fitzgerald from $34.00 to $33.00. They currently have an overweight rating on the stock.

Keurig Dr Pepper (NASDAQ:KDP) had its price target boosted by Morgan Stanley from $38.00 to $40.00. Morgan Stanley currently has an overweight rating on the stock.

Largo (NYSE:LGO) had its price target trimmed by HC Wainwright to $0.90. They currently have a buy rating on the stock.

Neutron (NASDAQ:LIME) had its price target reduced by Citizens Jmp from $33.00 to $27.00. Citizens Jmp currently has a market outperform rating on the stock.

LivaNova (NASDAQ:LIVN) had its target price increased by Needham & Company LLC from $93.00 to $112.00. They currently have a buy rating on the stock.

Louisiana-Pacific (NYSE:LPX) had its target price increased by Royal Bank Of Canada from $84.00 to $85.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Intuitive Machines (NASDAQ:LUNR) had its price target cut by B. Riley Financial from $43.00 to $34.00. B. Riley Financial currently has a buy rating on the stock.

Ramaco Resources (NASDAQ:METC) had its price target lowered by B. Riley Financial from $24.00 to $17.00. B. Riley Financial currently has a buy rating on the stock.

Ramaco Resources (NASDAQ:METC) had its price target cut by The Goldman Sachs Group from $8.00 to $7.00. They currently have a neutral rating on the stock.

Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target increased by Citizens Jmp from $144.00 to $167.00. The firm currently has a market outperform rating on the stock.

Mirum Pharmaceuticals (NASDAQ:MIRM) had its target price raised by Cantor Fitzgerald from $155.00 to $160.00. They currently have an overweight rating on the stock.

Mirum Pharmaceuticals (NASDAQ:MIRM) had its target price boosted by HC Wainwright from $200.00 to $202.00. The firm currently has a buy rating on the stock.

Modine Manufacturing (NYSE:MOD) had its target price cut by KeyCorp from $280.00 to $225.00. They currently have an overweight rating on the stock.

Mvb Financial (NASDAQ:MVBF) had its target price reduced by Keefe, Bruyette & Woods from $34.00 to $31.00. The firm currently has an outperform rating on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its price target increased by Guggenheim from $207.00 to $224.00. Guggenheim currently has a buy rating on the stock.

Nuveen Churchill Direct Lending (NYSE:NCDL) had its target price cut by Keefe, Bruyette & Woods from $13.50 to $13.00. The firm currently has a market perform rating on the stock.

Nurix Therapeutics (NASDAQ:NRIX) had its price target cut by Wells Fargo & Company from $25.00 to $20.00. They currently have an overweight rating on the stock.

Neostellar Capital (NASDAQ:NSLR) had its price target lowered by BTIG Research from $14.00 to $13.00. They currently have a buy rating on the stock.

Nucor (NYSE:NUE) had its price target raised by KeyCorp from $286.00 to $301.00. The firm currently has an overweight rating on the stock.

Navitas Semiconductor (NASDAQ:NVTS) had its price target cut by Needham & Company LLC from $21.00 to $15.00. The firm currently has a buy rating on the stock.

Oculis (NASDAQ:OCS) had its target price trimmed by Guggenheim to $40.00. Guggenheim currently has a buy rating on the stock.

OneMain (NYSE:OMF) had its target price lowered by Wells Fargo & Company from $65.00 to $62.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Pets at Home Group (LON:PETS) had its price target boosted by Jefferies Financial Group from GBX 265 to GBX 305. The firm currently has a buy rating on the stock.

Pfizer (NYSE:PFE) had its price target increased by Royal Bank Of Canada from $25.00 to $28.00. The firm currently has a sector perform rating on the stock.

PJT Partners (NYSE:PJT) had its price target trimmed by Keefe, Bruyette & Woods from $159.00 to $155.00. The firm currently has a market perform rating on the stock.

People Incorporated Common Stock (NASDAQ:PPLI) had its target price trimmed by Citizens Jmp from $54.00 to $47.00. Citizens Jmp currently has a market outperform rating on the stock.

People Incorporated Common Stock (NASDAQ:PPLI) had its target price cut by KeyCorp from $50.00 to $44.00. The firm currently has an overweight rating on the stock.

People Incorporated Common Stock (NASDAQ:PPLI) had its target price cut by Truist Financial from $62.00 to $59.00. They currently have a buy rating on the stock.

People Incorporated Common Stock (NASDAQ:PPLI) had its target price lowered by The Goldman Sachs Group from $63.00 to $56.00. The firm currently has a buy rating on the stock.

Pershing Square (NYSE:PS) had its price target raised by Royal Bank Of Canada from $44.00 to $45.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Phoenix Education Partners (NYSE:PXED) had its price target reduced by Truist Financial from $38.00 to $23.00. Truist Financial currently has a hold rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target cut by Wedbush from $25.00 to $22.00. They currently have a neutral rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its target price increased by Wells Fargo & Company from $18.00 to $19.00. They currently have an equal weight rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target trimmed by The Goldman Sachs Group from $19.00 to $17.00. The Goldman Sachs Group currently has a neutral rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its target price boosted by Morgan Stanley from $20.00 to $22.00. Morgan Stanley currently has an equal weight rating on the stock.

Red Rock Resorts (NASDAQ:RRR) had its price target reduced by Citizens Jmp from $71.00 to $70.00. The firm currently has a market outperform rating on the stock.

Revolve Group (NYSE:RVLV) had its target price lowered by Piper Sandler from $30.00 to $26.00. Piper Sandler currently has an overweight rating on the stock.

Revvity (NYSE:RVTY) had its price target raised by Royal Bank Of Canada from $135.00 to $172.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

RxSight (NASDAQ:RXST) had its target price lowered by Piper Sandler from $10.00 to $8.00. The firm currently has a neutral rating on the stock.

RxSight (NASDAQ:RXST) had its target price cut by Needham & Company LLC from $11.00 to $7.00. They currently have a buy rating on the stock.

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target increased by Citizens Jmp from $160.00 to $166.00. The firm currently has a market outperform rating on the stock.

Safehold (NYSE:SAFE) had its target price reduced by Royal Bank Of Canada from $13.00 to $12.00. They currently have a sector perform rating on the stock.

SBA Communications (NASDAQ:SBAC) had its target price cut by Truist Financial from $238.00 to $235.00. The firm currently has a buy rating on the stock.

Septerna (NASDAQ:SEPN) had its price target increased by Wells Fargo & Company from $50.00 to $61.00. The firm currently has an overweight rating on the stock.

Super Group (SGHC) (NYSE:SGHC) had its target price trimmed by BTIG Research from $19.00 to $16.00. The firm currently has a buy rating on the stock.

Shopify (NASDAQ:SHOP) (TSE:SHOP) had its target price cut by Rosenblatt Securities from $186.00 to $180.00. They currently have a buy rating on the stock.

Shopify (NASDAQ:SHOP) (TSE:SHOP) had its price target reduced by Cantor Fitzgerald from $158.00 to $150.00. Cantor Fitzgerald currently has a neutral rating on the stock.

Super Micro Computer (NASDAQ:SMCI) had its price target raised by Bank of America from $38.00 to $39.00. Bank of America currently has an underperform rating on the stock.

Smiths News (LON:SNWS) had its price target increased by Berenberg Bank from GBX 88 to GBX 110. They currently have a buy rating on the stock.

Smiths News (LON:SNWS) had its target price raised by Canaccord Genuity Group from GBX 95 to GBX 105. They currently have a buy rating on the stock.

Sprout Social (NASDAQ:SPT) had its price target boosted by KeyCorp from $7.00 to $10.00. The firm currently has an underweight rating on the stock.

Sprout Social (NASDAQ:SPT) had its target price increased by Cantor Fitzgerald from $8.00 to $13.00. They currently have a neutral rating on the stock.

Sportradar Group (NASDAQ:SRAD) had its target price lowered by Citizens Jmp from $20.00 to $19.00. They currently have a market outperform rating on the stock.

Sportradar Group (NASDAQ:SRAD) had its target price reduced by Guggenheim from $26.00 to $23.00. They currently have a buy rating on the stock.

Sportradar Group (NASDAQ:SRAD) had its price target boosted by Truist Financial from $16.00 to $17.00. Truist Financial currently has a buy rating on the stock.

Starwood Property Trust (NYSE:STWD) had its target price cut by Keefe, Bruyette & Woods from $16.00 to $15.00. The firm currently has an outperform rating on the stock.

Supernus Pharmaceuticals (NASDAQ:SUPN) had its target price increased by Cantor Fitzgerald from $67.00 to $87.00. Cantor Fitzgerald currently has an overweight rating on the stock.

Skyworks Solutions (NASDAQ:SWKS) had its target price cut by Susquehanna from $90.00 to $75.00. Susquehanna currently has a neutral rating on the stock.

Skyworks Solutions (NASDAQ:SWKS) had its target price lowered by Royal Bank Of Canada from $95.00 to $80.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Spyre Therapeutics (NASDAQ:SYRE) had its price target raised by Guggenheim from $130.00 to $135.00. They currently have a buy rating on the stock.

Spyre Therapeutics (NASDAQ:SYRE) had its price target reduced by Wedbush from $123.00 to $120.00. They currently have an outperform rating on the stock.

Sysco (NYSE:SYY) had its target price reduced by JPMorgan Chase & Co. from $95.00 to $92.00.

Tarsus Pharmaceuticals (NASDAQ:TARS) had its target price increased by HC Wainwright from $88.00 to $106.00. The firm currently has a buy rating on the stock.

LendingTree (NASDAQ:TREE) had its price target reduced by Truist Financial from $70.00 to $65.00. They currently have a buy rating on the stock.

Take-Two Interactive Software (NASDAQ:TTWO) had its price target lowered by BTIG Research from $313.00 to $262.00. They currently have a buy rating on the stock.

Travere Therapeutics (NASDAQ:TVTX) had its price target cut by Guggenheim from $89.00 to $78.00. The firm currently has a buy rating on the stock.

Uber Technologies (NYSE:UBER) had its price target reduced by BTIG Research from $100.00 to $90.00. The firm currently has a buy rating on the stock.

United Dominion Realty Trust (NYSE:UDR) had its price target increased by Royal Bank Of Canada from $37.00 to $38.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

UL Solutions (NYSE:ULS) had its target price boosted by Wells Fargo & Company from $104.00 to $105.00. They currently have an overweight rating on the stock.

Upstart (NASDAQ:UPST) had its price target lowered by The Goldman Sachs Group from $28.00 to $24.00. The Goldman Sachs Group currently has a neutral rating on the stock.

Upstart (NASDAQ:UPST) had its price target trimmed by Truist Financial from $40.00 to $30.00. They currently have a buy rating on the stock.

Upstart (NASDAQ:UPST) had its target price trimmed by Morgan Stanley from $35.00 to $24.00. Morgan Stanley currently has an equal weight rating on the stock.

United Therapeutics (NASDAQ:UTHR) had its target price increased by BTIG Research from $728.00 to $768.00. BTIG Research currently has a buy rating on the stock.

Valaris (NYSE:VAL) had its price target raised by Susquehanna from $86.00 to $91.00. They currently have a neutral rating on the stock.

VICI Properties (NYSE:VICI) had its target price lowered by Cantor Fitzgerald from $32.00 to $29.00. They currently have an overweight rating on the stock.

Vital Farms (NASDAQ:VITL) had its price target trimmed by Needham & Company LLC from $14.00 to $13.00. Needham & Company LLC currently has a buy rating on the stock.

Vulcan Materials (NYSE:VMC) had its price target trimmed by Morgan Stanley from $321.00 to $311.00. The firm currently has an equal weight rating on the stock.

Viper Energy (NASDAQ:VNOM) had its target price boosted by Truist Financial from $53.00 to $54.00. Truist Financial currently has a buy rating on the stock.

Voyager Technologies (NYSE:VOYG) had its price target lowered by BTIG Research from $55.00 to $50.00. They currently have a buy rating on the stock.

Varonis Systems (NASDAQ:VRNS) had its target price cut by Cantor Fitzgerald from $55.00 to $49.75. Cantor Fitzgerald currently has an overweight rating on the stock.

Verra Mobility (NASDAQ:VRRM) had its price target cut by Morgan Stanley from $5.00 to $3.00. The firm currently has an equal weight rating on the stock.

V2X (NYSE:VVX) had its price target raised by BTIG Research from $90.00 to $95.00. BTIG Research currently has a buy rating on the stock.

Waters (NYSE:WAT) had its price target raised by KeyCorp from $460.00 to $500.00. The firm currently has an overweight rating on the stock.

Waters (NYSE:WAT) had its target price raised by Royal Bank Of Canada from $475.00 to $525.00. They currently have an outperform rating on the stock.

Waystar (NASDAQ:WAY) had its price target boosted by Truist Financial from $33.00 to $35.00. The firm currently has a buy rating on the stock.

XPLR Infrastructure (NYSE:XIFR) had its target price lowered by Royal Bank Of Canada from $14.00 to $12.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Xometry (NASDAQ:XMTR) had its target price increased by Royal Bank Of Canada from $100.00 to $117.00. They currently have a sector perform rating on the stock.

Xometry (NASDAQ:XMTR) had its price target boosted by Cantor Fitzgerald from $110.00 to $114.00. They currently have an overweight rating on the stock.

Xometry (NASDAQ:XMTR) had its target price raised by Rosenblatt Securities from $120.00 to $130.00. The firm currently has a buy rating on the stock.

Xometry (NASDAQ:XMTR) had its price target boosted by Citizens Jmp from $120.00 to $135.00. The firm currently has a market outperform rating on the stock.

Expro Group (NYSE:XPRO) had its target price cut by Piper Sandler from $16.00 to $15.00. The firm currently has an underweight rating on the stock.

Block (NYSE:XYZ) had its target price increased by Morgan Stanley from $80.00 to $82.00. The firm currently has an equal weight rating on the stock.

Block (NYSE:XYZ) had its price target raised by Royal Bank Of Canada from $95.00 to $103.00. They currently have an outperform rating on the stock.

Block (NYSE:XYZ) had its price target increased by Bank of America from $115.00 to $117.00. The firm currently has a buy rating on the stock.

Block (NYSE:XYZ) had its price target raised by Susquehanna from $100.00 to $110.00. They currently have a positive rating on the stock.

Zebra Technologies (NASDAQ:ZBRA) had its price target increased by Morgan Stanley from $360.00 to $380.00. Morgan Stanley currently has an equal weight rating on the stock.

Zebra Technologies (NASDAQ:ZBRA) had its price target lowered by BNP Paribas Exane from $460.00 to $455.00. BNP Paribas Exane currently has an outperform rating on the stock.